Prof Stephen Kent
Professorial Fellow
Department of Microbiology and Immunology
525 Scholarly works
100 Projects
HIGHLIGHTS
2026
Journal article
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity
DOI: 10.1038/s41467-026-73988-z2026
Journal article
In Vivo Blood Kinetics and Transcript Integrity of Three mRNA-Lipid Nanoparticle Vaccines in Humans.
DOI: 10.1021/acsnano.6c092262026
Journal article
Pre-existing systemic and nasal antibodies against avian H5 influenza A viruses vary according to childhood imprinting.
DOI: 10.1128/mbio.01892-262023
Research Grant
Biologics for the Prophylaxis and Treatment of COVID19
2022
Research grants (ARC, NHMRC, MRFF)
Immune Responses to SARS-CoV-2 Variants Across Age Groups and Vulnerable Populations
2021
Journal article
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences
DOI: 10.1183/13993003.03730-20202019
Research Grant
Addressing the Major Challenges in Hiv Vaccine and Cure Research
RECENT SCHOLARLY WORKS
2026
Journal article
Multi-omics integration reveals vaccine-specific molecular signatures and temporal dynamics of COVID-19 immune responses
DOI: 10.3389/fimmu.2026.18155432026
Journal article
Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations
DOI: 10.1002/advs.771452026
Journal article
Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities
DOI: 10.1016/j.addr.2026.1159252026
Journal article
Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis
DOI: 10.1371/journal.pmed.10052302026
Journal article
Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutinin.
DOI: 10.64898/2026.07.22.7399942026
Journal article
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren’s syndrome
DOI: 10.1038/s44321-026-00458-w2026
Journal article
Immune responses associated with protection from SARS-CoV-2 infection
DOI: 10.1016/j.vaccine.2026.128579
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
Antibody Cocktails Against COVID-19 - WHODrug Global License Agreement